| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | ||||||||||
-3,773 | 23 | -12,859 | - | - | - | - | - | - | - | - |
Cash flows from operating activities: | ||||||||||
Net Income (Loss) Attributable to Parent | ||||||||||
- | - | - | -14,913 | -9,187 | -7,766 | -8,019 | -10,007 | -9,981 | -16,891 | -11,917 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||
Depreciation and amortization | ||||||||||
124 | 169 | 262 | 251 | 222 | 145 | 150 | 297 | 376 | 523 | 578 |
Intangible asset impairment | ||||||||||
- | - | - | - | - | - | - | - | 192 | 0 | - |
Stock-based compensation | ||||||||||
190 | 446 | 209 | 225 | 302 | 289 | 245 | 319 | 837 | 1,184 | 2,132 |
AllowanceForDoubtfulAccountsCharge | ||||||||||
49 | 0 | - | - | - | - | - | - | - | - | - |
IdleFacilityImpairmentCharge | ||||||||||
400 | 0 | - | - | - | - | - | - | - | - | - |
Inventory Write-down | ||||||||||
2,595 | 0 | - | - | - | - | 151 | 234 | 98 | 2,075 | 363 |
Warrants offering costs | ||||||||||
- | - | - | - | 0 | -50 | -376 | 0 | 0 | - | -5,175 |
Fair Value Adjustment of Warrants | ||||||||||
- | - | -208 | -275 | -4,083 | -1,050 | 289 | 0 | 0 | - | - |
Changes in operating assets and liabilities: | ||||||||||
Accounts receivable | ||||||||||
-734 | -1,319 | 310 | -69 | 225 | 189 | -175 | -343 | -682 | -1,733 | -103 |
Inventories | ||||||||||
897 | 719 | 117 | 163 | 409 | 116 | -119 | -694 | -550 | -71 | -683 |
Increase (Decrease) In Collaboration Receivable | ||||||||||
189 | 0 | - | - | - | - | - | - | - | - | - |
Prepaid expenses and other current and long-term assets | ||||||||||
-243 | -358 | 884 | 754 | 447 | 195 | -52 | 76 | -110 | 199 | 90 |
Accounts payable | ||||||||||
-572 | 572 | -8 | -267 | 478 | 199 | 65 | -371 | 370 | -827 | 885 |
Accrued expenses | ||||||||||
-157 | -408 | 891 | 347 | 57 | 998 | -54 | -530 | 240 | -753 | -120 |
Increase (Decrease) in Accrued Product Returns | ||||||||||
-412 | -856 | 181 | - | - | - | - | - | - | - | - |
Increase (Decrease) in Contract with Customer, Liability | ||||||||||
- | - | 191 | - | - | - | - | - | - | - | - |
Increase (Decrease) in Accrued Liabilities | ||||||||||
- | - | - | - | - | - | - | - | - | - | -3,705 |
Increase (Decrease) in Deferred Collaboration Income | ||||||||||
-1,956 | 1,956 | 0 | - | - | - | - | - | - | - | - |
Deferred revenue | ||||||||||
- | - | - | 401 | 192 | -44 | -108 | - | - | - | - |
Deferred revenue, deferred costs, and other | ||||||||||
- | - | - | - | - | - | - | - | - | -223 | -225 |
Net Cash Provided by (Used in) Operating Activities | ||||||||||
-3,621 | 2,861 | -12,652 | - | - | - | - | - | -6,778 | -13,307 | -6,137 |
Deferred revenue, deferred costs, and other | ||||||||||
- | - | - | - | - | - | - | -78 | -256 | - | - |
Net cash provided by (used in) operating activities | ||||||||||
- | - | - | -15,080 | -13,099 | -7,678 | -6,554 | -9,175 | - | - | - |
Cash flows from investing activities: | ||||||||||
Purchases of investments | ||||||||||
- | - | - | - | - | - | - | - | - | - | 7,495 |
Maturities of investments | ||||||||||
- | - | - | - | - | - | - | - | - | 7,495 | 7,495 |
Purchases of fixed assets | ||||||||||
48 | 143 | 163 | 100 | 594 | 227 | 86 | 107 | 110 | 306 | 342 |
Repurchase of preferred stock and warrants | ||||||||||
- | - | - | - | 3,206 | 0 | 0 | - | - | - | - |
Net Cash Provided by (Used in) Investing Activities | ||||||||||
-48 | -143 | -163 | - | - | - | - | - | 67 | 7,188 | -692 |
Purchase of technological and intellectual property | ||||||||||
- | - | - | - | - | - | - | - | - | - | 350 |
Release of restricted cash | ||||||||||
- | - | - | - | - | - | - | -229 | -178 | 0 | - |
Net cash used in investing activities | ||||||||||
- | - | - | -100 | -594 | -227 | -86 | 122 | - | - | - |
Cash flows from financing activities: | ||||||||||
Net proceeds from issuance of stock and warrants | ||||||||||
15 | 18 | - | - | 20,141 | 7,932 | 7,155 | 7,482 | 33 | - | - |
Net proceeds from issuance of common stock and warrants, including public offering and equity plans | ||||||||||
- | - | - | - | - | - | - | - | - | 195 | 17,486 |
Payments on capital lease | ||||||||||
- | - | - | - | - | - | 17 | 20 | 19 | 27 | 22 |
Net cash provided by financing activities | ||||||||||
- | - | - | 6,667 | 16,935 | 7,932 | 7,137 | 7,462 | - | - | - |
Net Cash Provided by (Used in) Financing Activities | ||||||||||
15 | 18 | 12,910 | - | - | - | - | - | 14 | 167 | 17,464 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | ||||||||||
-3,654 | 2,736 | 94 | - | - | - | - | - | - | - | - |
Net proceeds from issuance of stock and warrants, including private offerings and equity plans | ||||||||||
- | - | 12,910 | 6,667 | - | - | - | - | - | - | - |
Net increase in cash and cash equivalents | ||||||||||
- | - | - | -8,513 | 3,240 | 26 | 496 | -1,590 | -6,696 | -5,950 | 10,635 |
Supplemental disclosure of cash flow information: | ||||||||||
Fixed asset additions included in accounts payable | ||||||||||
- | - | - | 0 | - | - | - | - | - | - | - |
Change in fair value of warrant liability from repricing | ||||||||||
- | - | 244 | 0 | - | - | - | - | - | - | - |
Exchange of warrant liability for Series F Preferred Stock | ||||||||||
- | - | 40 | 0 | - | - | - | - | - | - | - |
Stock Issuance Settle Incentive Compensation Obligation | ||||||||||
0 | 294 | 0 | 318 | -281 | -104 | -285 | 0 | 0 | - | - |
Equity offering costs included in accounts payable and accrued expenses | ||||||||||
- | - | - | - | 100 | 0 | 0 | - | - | - | - |
Warrants issued under Securities Purchase Agreement initially recorded as a non-current liability | ||||||||||
- | - | - | - | 0 | 4,418 | 4,011 | 0 | 0 | - | 14,496 |
Capital Expenditures Incurred but Not yet Paid | ||||||||||
- | - | 7 | - | - | - | - | - | - | - | - |
Equipment acquired under capital lease, net | ||||||||||
- | - | - | - | - | - | - | - | - | 60 | - |
Common stock issued in exchange for warrants | ||||||||||
- | - | - | - | - | - | - | 127 | 0 | 0 | 97 |
Warrants Issued In Public Offering | ||||||||||
- | - | - | - | - | - | - | 2,373 | 0 | 0 | - |
Warrants liability reclassified to additional paid-in capital upon exercise of warrants | ||||||||||
- | - | - | - | - | - | 2,362 | 0 | 0 | - | - |